Issue amount at full subscription
94,1 MSEK
Subscriptions and warranty commitments
Subscription commitments of approximately 5,0 MSEK and warranty commitments of approximately 89,1 MSEK have been entered into, which corresponds to approximately 100% of 94,1 MSEK.
Preference right and subscription rights
Anyone who was registered as a shareholder at the record date November 20th of 2020 has preference rights to subscribe for shares in the Rights Issue and will receive one (1) Unit right for each share held. Five (5) Unit rights entitles to subscription of seven (7) shares and two (2) warrants of series 2020/2022:1. In addition, shareholders and other investors are being offered without preferential right to register an interest in subscribing for new shares.
Subscription course
66,50 SEK per Unit, corresponding to 9,50 SEK per share
Subscription time
November 25th – December 9th, 2020
Trade with subscription rights
November 25th – December 7th, 2020
Trade with BTA
Trade with BTU will occur at Nasdaq First North Growth Market starting November 25th 2020 until conversion of BTU to shares and warrants, which is expected to take place about a week after the Company has registered the issue. Such registration is estimated to take place around week 53, 2020.
ISIN codes at Nasdaq First North Growth Market
Share – CHRO SE0009496268
Unit right – CHRO UR. ISIN: SE0015195326
Paid unit right – CHRO BTU. ISIN: SE0015195334
Warrant – CHRO TO 3. ISIN: SE0015195367
- Download the issue folder here
- Download the Prospectus here
- Download the application form without support here
- Download the application form with support here
- Download press release here
- Download the auditor statement here
- Download the additional Prospectus here
Documents available for inspection
The Company’s registration certificate, memorandum of association, articles of association as well as the historic financial information available to the Company for the two latest financial years before the publication of this Prospectus are available in paper form at the Company’s office with the address Ullforsgatan 15, 752 28 Uppsala. Copies of these documents are available during the period of validity of the Prospectus at the office of ChromoGenics during regular business hours. The documents are also available at the Company’s website, www.chromogenics.com.
Documents incorporated by reference
Year-end report 2018
- The Company’s income statement (page 27)
- The Company’s balance sheet (pages 28-29)
- The Company’s report over changes in equity (page 30)
- The Company’s cash flow analysis (page 31)
- Notes (pages 33-43)
- Audit report (pages 47-49)
Year-end report 2019
- The Company’s income statement (page 28)
- The Company’s balance sheet (pages 29-30)
- The Company’s report over changes in equity (page 31)
- The Company’s cash flow analysis (page 32)
- Notes (pages 33-48)
- Auditor report (pages 54-55)
Interim report for January 1st – September 30th 2020
- The Company’s income statement (page 10)
- The Company’s balance sheet (page 11)
- The Company’s report over changes in equity (page 12)
- The Company’s cash flow analysis (page 12)
- Notes (pages 13-15)
